Read more

December 03, 2023
1 min read
Save

Neovascular AMD treatment in ‘last push’ of development; IOL positioning system launches

Healio’s top video perspectives from Eyecelerator@AAO include a key update on sozinibercept for neovascular age-related macular degeneration and a launch announcement for the ZeptoLink IOL positioning system.

Check out these items and more below.

Graphic distinguishing meeting news
Healio’s top video perspectives from Eyecelerator@AAO include a key update on sozinibercept for neovascular age-related macular degeneration and a launch announcement for the ZeptoLink IOL positioning system.

VIDEO: Sozinibercept in last push of phase 3 clinical development

Megan Baldwin, PhD, of Opthea shares an update on sozinibercept, a VEGF-C/D inhibitor for the treatment of neovascular age-related macular degeneration. Watch here.

VIDEO: Centricity Vision launches ZeptoLink IOL positioning system

Rob Thornhill of Centricity Vision announces the launch of the ZeptoLink IOL positioning system. Watch here.

VIDEO: Progressive pediatric myopia treatment at the tail end of phase 3 clinical trial

Nick Ruth, MBA, of Sydnexis previews upcoming data for a progressive myopia treatment for pediatric patients. Watch here.

VIDEO: Bausch + Lomb rolls out new cataract, refractive technologies
of Bausch + Lomb overviews three recently launched refractive cataract technologies from the company. Watch here.

VIDEO: APX3330 shows promise in slowing diabetic retinopathy progression
George Magrath, MD, MBA, MS,
CEO of Ocuphire Pharma, provides an update on APX3330 for the treatment of diabetic retinopathy. Watch here.